The human cytomegalovirus terminase complex as an antiviral target: a close-up view-Reference-Cited by-同舟云学术

The human cytomegalovirus terminase complex as an antiviral target: a close-up view

Published:2018-01-18 Issue:2 Volume:42 Page:137-145
ISSN:1574-6976
Container-title:FEMS Microbiology Reviews
language:en
Short-container-title:

Author:

Ligat G¹²^ORCID,Cazal R¹²,Hantz S¹²^ORCID,Alain S¹²^ORCID

Affiliation:

1. Université Limoges, INSERM, CHU Limoges, UMR 1092, 2 rue Dr Marcland, 87000 Limoges, France

2. CHU Limoges, Laboratoire de Bactériologie-Virologie-Hygiène, National Reference Center for Herpesviruses (NRHV), 2 avenue Martin Luther King, 87000 Limoges, France

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology

Link

http://academic.oup.com/femsre/article-pdf/42/2/137/24864997/fuy004.pdf

Reference66 articles.

1. Herpes simplex virus type 1 UL28 gene product is important for the formation of mature capsids;Addison;J Gen Virol,1990

2. Common ancestry of herpesviruses and tailed DNA bacteriophages;Baker;J Virol,2005

3. DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells;Beard;J Virol,2002

4. Bacteriophage lambda DNA: the beginning of the end;Becker;J Bacteriol,1990

5. Structural analysis of DNA cleaved in vivo by bacteriophage T4 terminase;Bhattacharyya;Gene,1994

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus infection in gastroenterology;Terapevticheskii arkhiv;2024-09-14

2. Detection of four isomers of the human cytomegalovirus genome using nanopore long-read sequencing;Virus Genes;2024-06-11

3. Real‐life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients;Clinical Transplantation;2024-04-30

4. Advances in pharmacotherapies for cytomegalovirus infection: what is the current state of play?;Expert Opinion on Pharmacotherapy;2024-04-12

5. Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir;Infectious Disease Reports;2024-01-18